Northwire Canada EditionFriday, October 16, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4170.10 +1.5% SILVER 57.16 +2.3% COPPER 6.56 −1.5% OIL 97.97 +3.0% PALLADIUM 1136.00 +3.6% LUN 32.91 +0.6% DLP 0.290 −3.3% VCV 0.065 −13.3% GG 2.89 +1.4% NBLC 0.015 +0.0% SF 0.300 −4.8% ATY 0.215 +2.4% GHL 0.060 −7.7% STND 0.060 −7.7% B 0.550 −3.5% HBM 34.33 −0.5% NTR 98.77 −0.7% SGZ 0.035 +0.0% MKA 0.670 +0.0% LXM 0.175 −18.6% CLCH 1.08 −1.8% GOLD 4170.10 +1.5% SILVER 57.16 +2.3% COPPER 6.56 −1.5% OIL 97.97 +3.0% PALLADIUM 1136.00 +3.6% LUN 32.91 +0.6% DLP 0.290 −3.3% VCV 0.065 −13.3% GG 2.89 +1.4% NBLC 0.015 +0.0% SF 0.300 −4.8% ATY 0.215 +2.4% GHL 0.060 −7.7% STND 0.060 −7.7% B 0.550 −3.5% HBM 34.33 −0.5% NTR 98.77 −0.7% SGZ 0.035 +0.0% MKA 0.670 +0.0% LXM 0.175 −18.6% CLCH 1.08 −1.8%
Financings

Rocket Doctor AI receives $1.94M from warrant exercise

By The Northwire Desk — AI Analysis Mar 17, 2026 · 18:02 AIDR · 0.65 Rocket Doctor AI Inc
AIDR · Price

Executive Summary

  • Rocket Doctor AI Inc. announced the exercise of outstanding common share purchase warrants, generating approximately $2.05 million in aggregate gross proceeds.
  • The exercises occurred between July 5, 2024, and March 13, 2026, involving warrants originally issued during a March 2024 private placement and April 2024 debt settlement units.
  • Proceeds will be allocated to working capital and general corporate purposes, with management citing sustained shareholder confidence in the company's AI-powered healthcare platform and 2026 U.S. growth initiatives.

Key Details

  • Aggregate Gross Proceeds: ~$2,048,938
  • Private Placement Warrants Exercised: 3,242,030 warrants at $0.60 each (~$1,945,218)
  • Debt Settlement Unit Warrants Exercised: 172,866 warrants at $0.60 each (~$103,720)
  • Recent Exercise Volume (3 months prior to March 13, 2026): 2,054,224 warrants (~$1,232,535)
  • Exercise Price: $0.60 per warrant
  • Warrant Expiration Dates: March 13, 2026 (private placement) and April 5, 2026 (debt settlement units)
  • Use of Proceeds: Working capital and general corporate purposes

Notable Quotes

  • "The exercise of these warrants reflects continued confidence in Rocket Doctor AI's strategy and long-term vision," said Dr. Essam Hamza, chief executive officer. "We appreciate the ongoing support from our shareholders as we continue to expand our AI-powered health care platform and focus on our 2026 U.S. growth plans."
Read the original news release →

More from Rocket Doctor AI Inc

Jun 30, 2026 · 08:00

Rocket Doctor Enters into a Primary Care Value-Based Care Agreement in the United States, Expanding In-Network Coverage by More Than 5 Million Members

M&A / Property Jun 23, 2026 · 08:00

AI-driven telemedicine platform expanding U.S. payer network, but burning cash with a going concern warning.

M&A / Property Jun 18, 2026 · 08:00

AI-driven telehealth platform scaling U.S. payer network, but burning cash and diluting equity to fund marketing.

M&A / Property Jun 16, 2026 · 08:00

AI-driven telehealth platform scaling U.S. payer access while burning cash to fund growth and R&D.

Other Jun 08, 2026 · 08:00

Rocket Doctor AI Launches a Strategic Marketing Partnership with Rick Ware Racing and FINTEKK AP for the 2026 NASCAR Cup Series, NHRA (National Hot Rod Association), World Supercross Championship, AFT (AMA - American Flat Track) and other Nationally telev

M&A / Property Jun 02, 2026 · 08:00

AI Virtual Care Platform Accelerates U.S. Visits and Secures Cash Runway, But Margin Compression and Going Concern Doubts Loom

Earnings